Global Radiotheranostics Market Size is valued at USD 2.54 billion in 2024 and is predicted to reach USD 8.73 billion by the year 2034 at an 6.0% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Radiotheranostics is a division of radiology that combines molecular imaging (primarily PET and SPECT) with targeted radionuclide therapy, which involves the use of small molecules, peptides, and/or antibodies as carriers for therapeutic radionuclides, typically those emitting -, -, or auger-radiation. The approval of new radiotheranostic agents such as 177Lu-DOTATATE and 177Lu-PSMA-617, as well as the availability of companion diagnostic agents (such as 68Ga-DOTATATE and 68Ga-PSMA-11, respectively), has fueled a resurgence of interest in the field, fueling a slew of clinical trials testing novel radiotheranostics.
Increased public-private funding for target research initiatives, growing public awareness of the advantages of alpha radio immunotherapy-based targeted cancer treatment, and increased product innovations and development due to global technological advancements is expected to create lucrative opportunities for market participants during the forecast period. Hospital budget cuts, particularly during the pandemic, a lack of sufficient infrastructure in low- and middle-income nations, and an unfavorable reimbursement environment are all anticipated to pose challenges to the market throughout the projection period.
Increasing investment in R&D, particularly in developed and developing economies, for medical instruments and devices will further open up lucrative market expansion opportunities. The nuclear medical field's research and development capabilities also support the market growth rate. Growing numbers of strategic alliances and partnerships between public and private players are opening up lucrative new market opportunities for the funding and use of cutting-edge technology.
The radiotheranostics market is segmented on the radioisotope, source, approach, applications and end users. Based on radioisotope, the market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, 18F, y-90, lutetium (lu) 177, copper (Cu) 67, copper (Cu) 64, others. Based on source, the market is segmented into Nuclear Reactors, Cyclotrons. Based on approach market is segmented into Targeted Therapeutic (Rx), Companion Diagnostic (DX). Based on application, the radiotheranostics market is segmented into oncology (thyroid cancer, neuroendocrine cancer, hepatocellular carcinoma, multiple myeloma, lymphoma, others) and non-oncology (joint infections, arthritis, bone pain, others). Based on end-use, the radiotheranostics market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies and others.
177 Lu segment grabbed the highest revenue share, and it is anticipated that they will continue to hold that position during the anticipated time. The majority of radioisotopes are employed in oncology for radiation therapy or diagnosis. Theranostics frequently utilized in diagnosing and treating neuroendocrine tumors include 68 Ga DONATE and 177 Lu DOTATOC. The main causes of the intense interest in the clinical application of this radionuclide are its good nuclear properties and the simplicity of obtaining high activity levels of 177Lu.
Cyclotrons are fast evolving and will play an increasingly significant role in the pharmaceutical industry, particularly in advanced medical imaging techniques, since radiopharmaceuticals generated by cyclotrons are exceptionally effective at identifying various diseases.
The North American radiotheranostics market is expected to register the highest market share in revenue soon because of the region's robust healthcare infrastructure, rising overweight population, large patient population suffering from chronic diseases like cancer, coronary artery disease, and strokes, and increased research activity. In addition, Asia Pacific is projected to grow rapidly in the global radiotheranostics market. However, this business is still expected to have substantial development potential due to the expanding number of clinical settings where flow cytometry is used.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 2.54 billion |
|
Revenue Forecast In 2034 |
USD 8,73 billion |
|
Growth Rate CAGR |
CAGR of 6.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Radioisotope, Source, Approach, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Novartis AG, Bayer AG, Telix Pharmaceuticals, ITM Isotope Technologies, Eli Lilly (via POINT Biopharma), AstraZeneca (via Fusion Pharmaceuticals), Radiopharm Theranostics, Nordic Nanovector, Y-mAbs Therapeutics, Ratio Therapeutics, Radionetics Oncology |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Radiotheranostics Market By Radioisotope:
Radiotheranostics Market By Source
Radiotheranostics Market By Approach
Radiotheranostics Market By Application:
Radiotheranostics Market By End User:
North America Radiotheranostics Market By Country,
Europe Radiotheranostics Market By Country,
Asia Pacific Radiotheranostics Market By Country,
Latin America Radiotheranostics Market By Country,
Middle East & Africa Radiotheranostics Market By Country,
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
